-
-
-
-
-
-
-
Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
SECURITIES FRAUD CLASS ACTIONS SURVIVE MOTIONS TO DISMISS: Grabar Law Office Investigates Claims on Behalf of Shareholders of Arqit Quantum Inc. (NASDAQ: ARQQ); Axsome Therapeutics, Inc. (NASDAQ: AXSM
-
-
-
-
-
-
-
Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
-
-
-
-
-
-
-
Axsome Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Axsome Therapeutics Completes U.S. Acquisition of SunosiĀ® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) Acquires Sunosi from Jazz Pharmaceuticals (JAZZ)
-
-
-
-
-
-
-
Pre-Open 12/19: (PRTK) (RAD) (TIVO) Higher (NERV) (APOG) (XPER) Lower (more...)
-
1,156,078 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

